H.B. Fuller Company (FUL) 株式分析

企業概要

H.B. Fuller Company is a leading formulator, manufacturer, and marketer of specialty chemical products, including adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialized solutions tailored for diverse industrial applications. The corporation operates within the Basic Materials sector, specifically the Specialty Chemicals industry, a segment characterized by the production of essential inputs for manufacturing processes across hygiene, health, engineering, and construction markets. As of the latest data, the company holds a market capitalization of $3.47B and generates annual revenue totaling $3.46B, supported by a workforce of 7,100 employees. These valuation and revenue metrics indicate that H.B. Fuller is a mid-to-large cap entity with a substantial operational footprint, positioning it as a significant player capable of influencing supply chains while maintaining a balance between profitability and market reach.

財務健全性

The company reported a trailing twelve-month revenue of $3.46B, accompanied by a net income of $159.76M and an EBITDA of $585.93M. The substantial disparity between the gross revenue figure and the net income amount reveals a cost structure where operating expenses, taxes, and interest charges collectively consume approximately 95.4% of total revenue before arriving at the bottom line. Furthermore, the free cash flow stands at $205.81M, which signifies that the business generates sufficient liquidity to fund operations, service debt obligations, and potentially return capital to shareholders without relying on external financing. Profitability analysis shows a gross margin of 31.9%, indicating the efficiency of production and pricing power before overhead costs; an operating margin of 8.4% demonstrates the company's ability to control its overhead and scale operations; and a profit margin of 4.6% reflects the final earnings available to shareholders after all expenses. Regarding capital structure, the company holds $107.88M in cash against total debt of $2.23B, resulting in a debt-to-equity ratio of 107.91, which suggests a leveraged balance sheet typical for capital-intensive manufacturing industries rather than a conservative cash-heavy stance. Liquidity is assessed via a current ratio of 1.92, indicating that the firm possesses sufficient current assets to cover its short-term liabilities nearly twice over, thereby ensuring stability in meeting immediate obligations. Additionally, the return on equity is 8.3% and the return on assets is 5.0%, metrics that reveal the management's effectiveness in generating returns relative to the shareholders' invested capital and the total asset base employed in the business.

バリュエーション評価

Valuation multiples indicate a trailing P/E ratio of 22.03 compared to a forward P/E of 12.39. The significant divergence between these two figures implies that the market expects a sharp acceleration in earnings growth in the future, as the current stock price is priced significantly higher relative to past earnings than it is relative to projected earnings. The price-to-book ratio is recorded at 1.68, suggesting that the market values the company at a 68% premium over its tangible book value, reflecting intangible assets, brand equity, or growth prospects not captured on the balance sheet. Alternative valuation metrics include a price-to-sales ratio of 1.00 and an EV/EBITDA of 9.54, which together suggest that the company trades at a valuation comparable to its sales revenue while maintaining an enterprise value relative to earnings that is moderate for the specialty chemicals sector. Price action over the last year shows a 52-week high of $68.63 and a 52-week low of $47.56, and without the current share price explicitly provided in the source data, the specific percentage distance from the high or low cannot be calculated, but the range defines the recent volatility envelope. The beta is 1.04, indicating that the stock's price volatility is slightly higher than the broader market, meaning it tends to move with greater magnitude than the general index during periods of market fluctuation.

Growth & Income

Growth metrics display a revenue growth rate of -2.3% year-over-year, contrasted with an earnings growth rate of 58.3% year-over-year. This dynamic indicates that earnings are growing substantially faster than revenue, a scenario often driven by margin expansion, cost reductions, or one-time adjustments rather than top-line volume increases. As a dividend payer, the company offers a dividend yield of 1.5% with a payout ratio of 32.5%. This payout ratio is considered sustainable given the current earnings level, as the company retains the majority of its profits for reinvestment or debt reduction while still distributing a portion of cash flow to shareholders. The overall growth and income profile is characterized by a period of revenue contraction offset by strong earnings expansion and a moderate, sustainable dividend yield, presenting a scenario where value is derived primarily from profitability improvements rather than business scale expansion.